[go: up one dir, main page]

MXPA04003480A - Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica. - Google Patents

Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica.

Info

Publication number
MXPA04003480A
MXPA04003480A MXPA04003480A MXPA04003480A MXPA04003480A MX PA04003480 A MXPA04003480 A MX PA04003480A MX PA04003480 A MXPA04003480 A MX PA04003480A MX PA04003480 A MXPA04003480 A MX PA04003480A MX PA04003480 A MXPA04003480 A MX PA04003480A
Authority
MX
Mexico
Prior art keywords
agent
brain
heart
substituted
imidazol
Prior art date
Application number
MXPA04003480A
Other languages
English (en)
Inventor
Marcel J M Borgers
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MXPA04003480A publication Critical patent/MXPA04003480A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion se relaciona con un agente para la reduccion de la lesion isquemica ocasionada a un organo, en especial a un corazon y un cerebro, composiciones farmaceuticas que comprenden dicho agente y el uso de dicho agente para el tratamiento de las enfermedades isquemicas del corazon y del cerebro, el agente comprende un derivado de 4-fenil-4-piperidina sustituida de acuerdo con la formula (I)(Ver dibujo)las sales de adicion de acido o base farmaceuticamente aceptables del mismo, las formas estereoquimicamente isomericas del mismo, las formas tautomericas del mismo, las formas de N-oxido del mismo y los profarmacos del mismo; se reclaman en especial los compuestos de conformidad con la formula (I) en los cuales A=B es C=O o >SO2, X es un enlace covalente, R1 es alquiloxi, alquiloxialquilo, Ar o NR9R10, donde cada uno de R9 y R10 es independientemente hidrogeno o Ar, o A=B y R1 juntos forman un radical benezoxazolilo; p es cero, R3 es bencilo optativamente sustituido con hidroxi, alquilo o alquiloxicarbonilo y cada uno de R4 y R5 es hidrogeno; el uso de dichos agentes tiene importantes ramificaciones clinicas en lo que respecta a la reduccion de la lesion isquemica ocasionada a un organo de un mamifero, en especial a un corazon y/o un cerebro, a la prevencion de enfermedades de las arterias coronarias en un mamifero mediante la induccion de un efecto cardioprotector y el tratamiento y prevencion de la apoplejia.
MXPA04003480A 2001-10-15 2002-10-10 Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica. MXPA04003480A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203927 2001-10-15
PCT/EP2002/011371 WO2003039440A2 (en) 2001-10-15 2002-10-10 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage

Publications (1)

Publication Number Publication Date
MXPA04003480A true MXPA04003480A (es) 2004-07-30

Family

ID=8181081

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003480A MXPA04003480A (es) 2001-10-15 2002-10-10 Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica.

Country Status (26)

Country Link
US (1) US7390822B2 (es)
EP (1) EP1438049B1 (es)
JP (1) JP4418676B2 (es)
KR (1) KR100967599B1 (es)
CN (1) CN1283252C (es)
AR (1) AR036800A1 (es)
AT (1) ATE345799T1 (es)
AU (1) AU2002363369B2 (es)
BR (1) BR0213325A (es)
CA (1) CA2462374C (es)
CY (1) CY1106335T1 (es)
DE (1) DE60216310T2 (es)
EA (1) EA007657B1 (es)
ES (1) ES2276980T3 (es)
HR (1) HRP20040325A2 (es)
HU (1) HUP0402332A3 (es)
IL (1) IL161347A0 (es)
MX (1) MXPA04003480A (es)
MY (1) MY139586A (es)
NO (1) NO20041681L (es)
NZ (1) NZ531733A (es)
PL (1) PL370371A1 (es)
PT (1) PT1438049E (es)
UA (1) UA75980C2 (es)
WO (1) WO2003039440A2 (es)
ZA (1) ZA200402816B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
AR044010A1 (es) * 2003-04-11 2005-08-24 Janssen Pharmaceutica Nv Uso de derivados de 4-fenil-4- [1h-imidazol-2-il]- piperidina sustituidos como agonistas delta opioideos no peptidos selectivos, con actividad antidepresiva y ansiolitica
WO2005005478A2 (en) * 2003-07-02 2005-01-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor; delta 1 (oprd1)
WO2005015242A1 (en) * 2003-08-06 2005-02-17 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor kappa 1 (opkr1)
TW200633990A (en) * 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
HRP20110510T1 (hr) * 2007-11-30 2011-08-31 Bayer Schering Pharma Aktiengesellschaft Heteroaril-supstituirani piperidini
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009056387B9 (de) * 2009-10-30 2020-05-07 Osram Opto Semiconductors Gmbh Kantenemittierender Halbleiterlaser mit einem Phasenstrukturbereich zur Selektion lateraler Lasermoden
IL273839B (en) 2017-10-19 2022-09-01 Amgen Inc Benzimidazole derivatives and their uses
CN113209294B (zh) * 2020-02-05 2023-06-13 复旦大学 Dor激动剂在制备对抗肾脏纤维化药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11511732A (ja) 1995-03-06 1999-10-12 インターニューロン ファーマシューティカルズ,インコーポレーテッド シチコリンを用いる梗塞容積の低減
CA2263890C (en) 1996-08-23 2013-05-14 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
AU7250298A (en) 1997-04-25 1998-11-24 Collateral Therapeutics, Inc. Truncated vegf-related proteins
US6103722A (en) * 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
GB2332373A (en) * 1997-12-19 1999-06-23 Merck & Co Inc Treatment of coronary and/or peripheral ischemia using an antithrombotic agent and an angiogenesis promoter
BR9916371A (pt) 1998-12-19 2001-09-18 Janssen Pharmaceutica Nv Composto de espiro anti-histamìnico
EP1038872A1 (en) * 1999-02-22 2000-09-27 Pfizer Products Inc. 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
US6297256B1 (en) * 1999-06-15 2001-10-02 Neurogen Corporation Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
ATE347549T1 (de) * 2001-10-15 2006-12-15 Janssen Pharmaceutica Nv Neue substituierte 4-phenyl-4-(1h-imidazo-2-yl)- piperidin-derivate und ihre anwendung als selective delta-opioid-agonisten
FR2831166B1 (fr) 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP1438049A2 (en) 2004-07-21
ATE345799T1 (de) 2006-12-15
PT1438049E (pt) 2007-02-28
WO2003039440A3 (en) 2003-12-18
CA2462374A1 (en) 2003-05-15
ES2276980T3 (es) 2007-07-01
EA200400547A1 (ru) 2004-10-28
HUP0402332A3 (en) 2009-07-28
CA2462374C (en) 2011-01-18
HK1072562A1 (en) 2005-09-02
EA007657B1 (ru) 2006-12-29
BR0213325A (pt) 2004-10-13
HRP20040325A2 (en) 2005-04-30
AR036800A1 (es) 2004-10-06
DE60216310D1 (de) 2007-01-04
NZ531733A (en) 2006-04-28
KR100967599B1 (ko) 2010-07-05
CN1283252C (zh) 2006-11-08
KR20050035120A (ko) 2005-04-15
CN1568186A (zh) 2005-01-19
EP1438049B1 (en) 2006-11-22
US20050004170A1 (en) 2005-01-06
ZA200402816B (en) 2005-06-29
UA75980C2 (en) 2006-06-15
CY1106335T1 (el) 2011-10-12
US7390822B2 (en) 2008-06-24
DE60216310T2 (de) 2007-06-21
NO20041681L (no) 2004-04-23
JP4418676B2 (ja) 2010-02-17
IL161347A0 (en) 2004-09-27
PL370371A1 (en) 2005-05-16
WO2003039440A2 (en) 2003-05-15
AU2002363369B2 (en) 2008-08-21
HUP0402332A2 (hu) 2005-02-28
JP2005507943A (ja) 2005-03-24
MY139586A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
CY1106335T1 (el) Υποκατεστημενα παραγωγα 4-φαινυλ-4[1η-ιμιδαζολ-2-υλ]-πιπepιδινης για τη μειωση της ισχαιμικης βλαβης
JP6142919B2 (ja) 血栓塞栓症の治療のための第XIa因子阻害剤としての置換ピロリジン
CY1106356T1 (el) Νεα υποκατεστημενα παραγωγα 4-φαινυλ-4-[1η-ιμιδαζολ-2-υλ]-πιπepιδινης και η χρηση τους ως επιλεκτικοι μη-πεπτιδικοι δελτα οπιοειδεις συναγωνιστες
JP2008526999A5 (es)
IL173397A0 (en) Pyridyl derivatives and their use as therapeutic agents
MY142807A (en) Benzimidazole derivative and use thereof.
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
TW200638935A (en) Pyridazine derivatives and their use as therapeutic agents
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
TW200616994A (en) Novel thiophene derivatives
TW200518753A (en) Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
JP6337750B2 (ja) 化合物
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
SG145570A1 (en) 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
CA2592345A1 (en) Piperidine and azetidine derivatives as glyt1 inhibitors
NO20053715L (no) 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk
TW200509913A (en) The use of substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity
MXPA06000269A (es) Tiofenilaminoimidazolinas.
TW273553B (es)
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
MXPA05014127A (es) Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras.
WO2009016812A1 (ja) 2-フェニルキノリン-4-カルボン酸誘導体を有効成分とする貧血の予防及び/又は治療剤
MY144229A (en) Pyridazine derivatives and their use as therapeutic agents
TW200638929A (en) Tricyclic cytoprotective compounds

Legal Events

Date Code Title Description
FG Grant or registration